Interestingly, TMPO is expressed at slightly lower levels in the patient line, which is, on its own, known to be associated with the DCM in patients.25 By contrast, SYNE2 has higher expression levels in the patient line, indicating that there are compensation mechanisms. This evidence concerns the gene TMPO and familial dilated cardiomyopathy.